SCHEMBL6665170

SCHEMBL6665170

Fc1ccc(Cn2cnc3ncnc(Cl)c32)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
HTT P42858 1/20 0.41
GAA P10253 1/20 0.40
PKM P14618 1/20 0.40
HPGD P15428 1/20 0.40
MAPT P10636 1/20 0.40
THRB P10828 1/20 0.40
CYP11B2 P19099 4/20 0.39
CYP11B1 P15538 3/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 1/20 0.39
HDAC6 Q9UBN7 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
SLC29A1 Q99808 1/20 0.37
CYP19A1 P11511 1/20 0.37
LMNA P02545 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
ADORA2A P29274 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3476218 0.84 ADORA2A (0.47) SMN1; SMN2GAAPKMCYP11B2CYP11B1
SCHEMBL6661754 0.84 ADORA2A (0.56) METSMN1; SMN2HTTMAPTCYP11B2
SCHEMBL29434725 0.81 ALDH1A1 (0.52) METSMN1; SMN2GAAHPGDMAPT
SCHEMBL22533664 0.81 HDAC6 (0.38) METSMN1; SMN2HTTCYP11B2CYP11B1
SCHEMBL29424810 0.81 HDAC6 (0.38) METSMN1; SMN2HTTCYP11B2CYP11B1
SCHEMBL20187539 0.81 ALDH1A1 (0.52) METSMN1; SMN2GAAHPGDMAPT
SCHEMBL27441624 0.81 HDAC6 (0.38) METSMN1; SMN2HTTCYP11B2CYP11B1
SCHEMBL6662357 0.80 MET (0.47) METSMN1; SMN2HTTGAAHPGD
Thiophene SCHEMBL28288723 0.77 ADORA2A (0.41) SMN1; SMN2GAAPKMCYP11B2CYP11B1
SCHEMBL6659705 0.76 HDAC6 (0.62) HDAC6SLC29A1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1444982-A1 The use of purine derivatives as selective kinase inhibitors MERCKLE GMBH (DE) 2004-08-11 EP disclosed